Retractable Technologies
RVP
#10103
Rank
C$34.02 M
Marketcap
C$1.14
Share price
-0.86%
Change (1 day)
26.18%
Change (1 year)
Categories

Revenue for Retractable Technologies (RVP)

Revenue in 2025 (TTM): C$53.16 Million

According to Retractable Technologies's latest financial reports the company's current revenue (TTM ) is C$53.21 Million. In 2024 the company made a revenue of C$47.42 Million a decrease over the revenue in the year 2023 that were of C$57.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Retractable Technologies from 2001 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$53.16 M12.11%
2024 C$47.42 M-17.98%
2023 C$57.82 M-55.06%
2022 C$0.12 B-46.41%
2021 C$0.24 B130.01%
2020 C$0.10 B91.21%
2019 C$54.58 M20.44%
2018 C$45.32 M4.52%
2017 C$43.36 M8.2%
2016 C$40.08 M-2.23%
2015 C$40.99 M2.33%
2014 C$40.06 M22.24%
2013 C$32.77 M-2.05%
2012 C$33.45 M2.45%
2011 C$32.65 M-9.81%
2010 C$36.2 M-11.73%
2009 C$41.01 M20.91%
2008 C$33.92 M29.34%
2007 C$26.22 M-11.05%
2006 C$29.48 M4.5%
2005 C$28.21 M9.15%
2004 C$25.84 M4.45%
2003 C$24.74 M-22.87%
2002 C$32.08 M24.75%
2001 C$25.72 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ICU Medical
ICUI
C$3.23 B 5,980.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$29.82 B 55,940.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
C$1.40 B 2,538.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Insulet
PODD
C$3.51 B 6,508.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.25 B 382.11%๐Ÿ‡บ๐Ÿ‡ธ USA